Estrellas Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.10 M
- Paid Up Capital ₹ 2.10 M
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.20 Cr
- Satisfied Charges ₹ 2.29 Cr
- Revenue Growth 40.43%
- Profit Growth 51.86%
- Ebitda 62.26%
- Net Worth 37.92%
- Total Assets 47.50%
About Estrellas Life Sciences
Estrellas Life Sciences Private Limited (ELSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 18 March 2013 and has a history of 11 years and 11 months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.10 M and a paid-up capital of Rs 2.10 M.
The company currently has active open charges totaling ₹4.20 Cr. The company has closed loans amounting to ₹2.29 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jay Dave and Shirish Dave serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239GJ2013PTC074048
- Company No.
074048
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Mar 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Estrellas Life Sciences Private Limited offer?
Estrellas Life Sciences Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Herbal Capsules, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Aceclofenac, Cardiovascular Drugs & Medication, Antidiabetic Medicine, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at Estrellas Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shirish Dave  | Director | 18-Mar-2013 | Current |
| Jay Dave | Director | 18-Mar-2013 | Current |
Financial Performance of Estrellas Life Sciences.
Estrellas Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 40.43% increase. The company also saw a substantial improvement in profitability, with a 51.86% increase in profit. The company's net worth Soared by an impressive increase of 37.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Estrellas Life Sciences?
In 2021, Estrellas Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Orfo Natura LlpShirish Dave is a mutual person
Charges (Loans)
₹42.00 M
₹22.88 M
Charges Breakdown by Lending Institutions
- The Kalupur Commercial Co-Operative Bank Limited : 4.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Jun 2021 | The Kalupur Commercial Co-Operative Bank Limited | ₹1.70 Cr | Open |
| 28 Dec 2020 | The Kalupur Commercial Co-Operative Bank Limited | ₹2.50 Cr | Open |
| 25 Sep 2019 | Others | ₹7.50 M | Satisfied |
| 05 Oct 2015 | Punjab National Bank | ₹1.05 Cr | Satisfied |
| 21 Oct 2014 | Punjab National Bank | ₹1.88 M | Satisfied |
How Many Employees Work at Estrellas Life Sciences?
Unlock and access historical data on people associated with Estrellas Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Estrellas Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Estrellas Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
